The treatment of children with synovial sarcoma
Abstract
Improvement of the results of treatment of synovial sarcoma in children and adolescents is the target of this study. 38 children and adolescents at the mean age of 10,5±3,7 years (18 males, 20 females) with synovial sarcoma were treated between 1999 and 2014 years in the Research Institution of Pediatric Oncology in the Russian Cancer Center. Treatment included chemotherapy, radiotherapy and surgical operation. The toxicity of intensive chemotherapy was reduced by support of peripheral blood stem cells in the investigation group of patients. 2-year disease-free survival was 66,1±11,3%, overall 5-year survival –75,6±10,6%.
About the Authors
D. B. Khestanov
Institute of Paediatric Oncology and Hematology N.N. Blokhin Cancer Research Center, Ministry of Health of Russian Federation
Russian Federation
Russian Federation
Moscow
E. R. Senzhapova
Institute of Paediatric Oncology and Hematology N.N. Blokhin Cancer Research Center, Ministry of Health of Russian Federation
Russian Federation
Russian Federation
Moscow
O. M. Romantsova
Institute of Paediatric Oncology and Hematology N.N. Blokhin Cancer Research Center, Ministry of Health of Russian Federation
Russian Federation
Russian Federation
Moscow
V. V. Kochieva
Institute of Paediatric Oncology and Hematology N.N. Blokhin Cancer Research Center, Ministry of Health of Russian Federation
Russian Federation
Russian Federation
Moscow
A. Z. Dzampaev
Institute of Paediatric Oncology and Hematology N.N. Blokhin Cancer Research Center, Ministry of Health of Russian Federation
Russian Federation
Russian Federation
Moscow
M. D. Aliev
Institute of Paediatric Oncology and Hematology N.N. Blokhin Cancer Research Center, Ministry of Health of Russian Federation
Russian Federation
Russian Federation
Moscow
References
1. Васильев Н.В. Синовиальная саркома. Оценка прогноза. Сибирский онкологический журнал. 2010, № 1, с. 73-78.
2. Brecht I.B., Ferrari A. et al. Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies. Pediatr. Blood Cancer. 2006, v. 46 (1), p. 11-17.
3. Casali P.G., Jost L., Sleijfer S. et al. ESMO Guidelines Working Group. Soft tissue sarcomas: ESMO clinical recommendations. Ann. Oncol. 2008, v. 19 (suppl. 2), p. ii89-ii93.
4. Casanova M., Meazza C. et al. Soft-tissue sarcomas of the extremities in patients of pediatric age. J. Child Orthop. 2007, v. 1 (3), p. 195-203.
5. Eilber F.C., Brennan M.F., Eilber F.R. et al. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann. Surg. 2007, v. 246, p. 105-113.
6. Ferrari A., Casanova M. et al. Synovial sarcoma: Report of a series of 25 consecutive children from a single institution. Med. and Pediat. Oncol. 1999, v. 32 (1), p. 32-37.
7. Ferrari A., Gronchi A., Casanova M. et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer. 2004, v. 101, p. 627-634.
8. Gofman A., Issakov J. et al. Synovial sarcoma of the extremities and trunk: a long-lasting disease. Oncol. Rep. 2007, v. 18 (6), p. 1577-1581.
9. Guadagnolo B.A., Zagars G.K. et al. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2007, v. 69 (4), p. 1173-1180. Epub 2007 Aug. 6.
10. Hasegawa T., Yamamoto S., Yokoyama R. et al. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk. Cancer. 2002, v. 95, p. 843-851.
11. Hawkins D., Felgenhauer J. et al. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas. Cancer. 2002, v. 95 (6), p. 1356-1365.
12. Kilpatrick S.E., Bergman S. et al. The usefulness of cytogenetic analysis in fine needle aspirates for the histologic subtyping of sarcomas. Modern Pathology. 2006, v. 19, p. 815-819.
13. Ladenstein R., Treuner J. et al. Synovial sarcoma of childhood and adolescence. Report of the German CWS-81 study. Cancer. 1993, v. 71, p. 3647-3655.
14. Lewis J.J., Antonescu C.R. et al. Synovial Sarcoma: A Multevariate Analysis of Prognostic Factors in 112 Patients with Primary Localized Tumors of the Extremity. J. Clin. Oncol. 2000, v. 18 (10), p. 2087-2094.
15. Miser J.S., Pappo A.S., Triche T.J. et al. Other soft tissue sarcomas of childhood. In: Pizzo P.A., Poplack D.G., editors. Principles and practice of pediatric oncology. Philadelphia, PA: Lippincott Williams&Wilkins. 2002, p. 1017-1050.
16. Okcu M.F., Despa S. et al. Synovial sarcoma in children and adolescents: thirty three years of experience with multimodal therapy. Med. Pediatr. Oncol. 2001, v. 37 (2), p. 90-96.
17. Okcu M.F., Munsell M. et al. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. J. Clin. Oncol. 2003, v. 21 (8), p. 1602-1611.
18. Palmerini E., Staals E.L. et al. Synovial sarcoma: retrospective analysis of 250 patients treated at a single institution. Сancer. 2009, v. 115 (13), p. 2988-2998.
19. Pisters P.W., Sullivan B.O., Maki R.G. Evidence-based recommendations for local therapy for soft tissue sarcomas. J. Clin. Oncol. 2007, v. 25, p. 1003-1008.
20. Ulmer C., Kettelhack C. et al. Synovial sarcoma of the extremities. Results of surgical and multimodal therapy. Chirurg. 2003, v. 74 (4), p. 370-374.
21. Weiss S.W., Goldblum J. Malignant soft tissue tumors of uncertain type. In: Weiss S.W., Goldblum J.R., editors. Enzingerand Weiss soft tissue tumors. St. Louis, Missouri: CV Mosby. 2001, p. 1483-1571.
22. Aydin O., Ersoz C., Ozbarlas S., Seydaoglu G. Assessment of proliferative activity in soft tissue sarcomas showing PCNA and Ki-67 reactivity immunohistochemically. Turk. J. Med. Sci. 2000, v. 30. p. 261-269.
23. Baptista A.M., de Camargo O.P., Croci А.Т. et al. Synovial sarcoma of the extremities: prognostic factors for 20 nonmetastatic cases and a new histologic grading system with prognostic significance. Clinics. 2006, v. 61 (5), p. 381-386.
24. Billings S.D., Meisner L.F., Cummings O.W., Tejada E. Synovial sarcoma of the upper digestive tract: a report of two cases with demonstration of the X; 18 translocation by fluorescence in situ hybridization. Mod. Pathol. 2000, v. 13 (1), p. 68-76.
25. Cormier J.N., Pollock R.E. Soft tissue sarcomas. Cancer J. Clin. 2004, v. 54 (94), p. 1-16.
26. Deyrup А.Т., Haydon R.C., Huo D. et al. Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity. Cancer. 2003, v. 98, p. 805-813.
27. Fletcher C.D.M., Unni К.К., Mertens F. eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; World Health Organization Classification of Tumors. 2002, v. 5.
28. Frazier A.A., Franks T.J., Pugatch R.D., Galvin J.R. From the Archives of the AFIP. Pleuropulmonary synovial sarcoma. Radiographics. 2006, v. 26 (3), p. 923-941.
29. Gabilondo F., Rodriguez F., Mohar A. et al. Primary synovial sarcoma of the kidney: corroboration with in situ polymerase chain reaction . Ann. Diagn. Pathol. 2008, v. 12 (2), p. 134-137.
30. Goto Y., Kawauchi S., Ihara K. et al. The prognosis in spindle-cell sarcoma depends on the expression of cyclin-dependent kinase inhibitor p27Kipi and cyclin E. Cancer Sci. 2003, v. 94, p. 412-417.
31. Guillou L., Benhattar J., Bonichon F. et al. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J. Clin. Oncol. 2004, v. 22, p. 4040-4050.
32. Hajdu S.I., Shiu M.H., Fortner J.G. Tendosynovial sarcoma: a clinical pathological study of 136 cases. Cancer. 1977, v. 39, p. 1201-1217.
33. Kawai A., Woodruff J., Healey J.H. et al. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N. Engl. J. Med. 1998, v. 338, p. 153-160.
34. Kilpatrick S.E., Geisinger K.R., King T.S. et al. Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma. Mod. Pathol. 2001, v. 14, p. 1277-1283.
35. Lee T.J., Chung J.H., Joh J.S. et al. Primary mediastinal synovial sarcoma. J. Lung Cancer. 2008, v. 7 (1), p. 29-33.
36. Lewis J.J., Antonescu C.R., Leung D.H.Y. et al. Synovial sarcoma: A multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J. Clin. Oncol. 2000, v. 18, p. 2087-2094.
37. Lopes J.M. Pathogenesis and prognostic parameters in synovial sarcoma. Rev. Esp. Patol. 2004, Short course 8, p. 430.
38. Machen S.K., Easley K.A., Goldblum J.R. Synovial sarcoma of the extremities: a clinicopathologic study of 34 cases, including semi-quantitative analysis of spindled, epithelial and poorly differentiated areas. Am. J. Surg. Pathol. 1999, v. 23, p. 268-275.
39. Morrison С., Wakely P.E. Jr., Ashman C.J. et al. Cystic synovial sarcoma. Ann. Diagn. Pathol. 2001, v. 5, p. 48-56.
40. Mullen J.R., Zagars G.K. Synovial sarcoma outcome following conservation surgery and radiotherapy. Radiother. Oncol. 1994, v. 33, p. 23-30.
41. Nagayama S., Katagiri Т., Tsunoda Т. et al. Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray. Cancer Res. 2002, v. 62, p. 5859-5866.
42. Ahmed Q., Tien S.L. et al. Primary pleural synovial sarcoma. Arch. Pathol. Lab. Med. 2003, v. 127, p. 85-90.
43. Oda Y., Hashimoto H., Takeshita S., Tsuneyoshi M. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma. Cancer. 1993, v. 72, p. 478-485.
44. Oda Y., Hashimoto H., Tsuneyoshi M., Takeshita S. Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival. Am. J. Surg. Pathol. 1993, v. 17, p. 35-44.
45. Okcu M.F., Munsell M., Treuner J. et al. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. J. Clin. Oncol. 2003, v. 21 (8), p. 1602-1611.
46. Rooser B., Willen H., Hugoson A., Rydholm A. Prognostic factors in synovial sarcoma. Cancer. 1989, v. 63, p. 2182-2185.
47. Sato O., Wada Т., Kawai A. et al. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas. Cancer. 2005, v. 103, p. 1881-1890.
48. Scmidt D., Thum P., Harms D., Treuner J. Synovial sarcoma in children and adolescents. A report from the Kiel Pediatric Tumor Registry. Cancer. 1991, v. 67, p. 1667-1672.
49. Siegel H.J., Sessions W., Cassillas M.A. Jr. et al. Synovial sarcoma: Clinicopathologic features, treatment, and prognosis. Orthopedics. 2007, v. 30, p. 1020-1029.
50. Singer S., Baldini E.H., Demetri G.D. et al. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J. Clin. Oncol. 1996, v. 14, p. 1201-1208.
51. Skubitz K.M., Dadamo D.R. Sarcoma. Mayo Clin. Proc. 2007, v. 82 (11), p. 1409-1432.
52. Skytting В., Meis-Kindblom J.M., Larsson O. et al. Synovial sarcoma – identification of favorable and unfavorable histologic types: a Scandinavian sarcoma group study of 104 cases. Acta Orthop. Scand. 1999, v. 70, p. 543-554.
53. Spillane A.J., A’Hern R., Judson I.R. et al. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J. Clin. Oncol. 2000, v. 18, p. 3794-3803.
54. Spurrell E.L., Fisher C., Thomas J.M., Judson I.R. Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital. Ann. Oncol. 2005, v. 16, p. 437-444.
55. Thompson R.C. Jr., Garg A., Goswitz J. et al. Synovial sarcoma. Large size predicts poor outcome. Clin. Orthop. Relat. Res. 2000, v. 373, p. 18-24.
56. Ueda Т., Aozasa K., Tsujimoto M. et al. Prognostic significance of mast cells in soft tissue sarcoma. Cancer. 1989, v. 63, p. 1607-1611.
57. Varela-Duran J., Enzinger F.M. Calcifying synovial sarcoma. Cancer. 1982, v. 50, p. 345-352.
58. Weiss S.W., Goldblum J.R., Enzinger F.M. Enzinger and Weiss’s Soft Tissue Tumors. 4-еd. St. Louis: Mosby Co. 2001.
59. Wen P., Prasad M.L. Synovial Sarcoma With Rhabdoid Features. Arch. Pathol. Lab. Med. 2003, v. 127 (10), p. 1391-1392.
60. White B.E., Kaplan A., Lopez-Terrada D.H. et al. Monophasic synovial sarcoma arising in the vulva. Arch. Pathol. Lab. Med. 2008, v. 132, p. 698-702.
61. Wright P.H., Sim F.H., Soule E.H., Taylor W.F. Synovial sarcoma. J. Bone Joint Surg. Am. 1982, v. 64, p. 112-122.
Review
For citations:
Khestanov D.B., Senzhapova E.R., Romantsova O.M., Kochieva V.V., Dzampaev A.Z., Aliev M.D. The treatment of children with synovial sarcoma. Bone and soft tissue sarcomas, tumors of the skin. 2016;(3):60-66. (In Russ.)
Views:
175
Email this article 
